News | May 07, 2023
Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Gafchromic films support patient care in oncology
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
